HIV-1 Gag specificity for PIP2 is regulated by macromolecular electric properties of both protein and membrane local environments

Biochim Biophys Acta Biomembr. 2023 Jun;1865(5):184157. doi: 10.1016/j.bbamem.2023.184157. Epub 2023 Apr 6.

Abstract

HIV-1 assembly occurs at the plasma membrane, with the Gag polyprotein playing a crucial role. Gag association with the membrane is directed by the matrix domain (MA), which is myristoylated and has a highly basic region that interacts with anionic lipids. Several pieces of evidence suggest that the presence of phosphatidylinositol-(4,5)-bisphosphate (PIP2) highly influences this binding. Furthermore, MA also interacts with nucleic acids, which is proposed to be important for the specificity of GAG for PIP2-containing membranes. It is hypothesized that RNA has a chaperone function by interacting with the MA domain, preventing Gag from associating with unspecific lipid interfaces. Here, we study the interaction of MA with monolayer and bilayer membrane systems, focusing on the specificity for PIP2 and on the possible effects of a Gag N-terminal peptide on impairing the binding for either RNA or membrane. We found that RNA decreases the kinetics of the protein association with lipid monolayers but has no effect on the selectivity for PIP2. Interestingly, for bilayer systems, this selectivity increases in presence of both the peptide and RNA, even for highly negatively charged compositions, where MA alone does not discriminate between membranes with or without PIP2. Therefore, we propose that the specificity of MA for PIP2-containing membranes might be related to the electrostatic properties of both membrane and protein local environments, rather than a simple difference in molecular affinities. This scenario provides a new understanding of the regulation mechanism, with a macromolecular view, rather than considering molecular interactions within a ligand-receptor model.

Keywords: HIV-1 Gag matrix domain; Human immunodeficiency virus; PIP(2); Protein-RNA interaction; Protein-membrane interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • HIV-1* / metabolism
  • Lipids / chemistry
  • Peptides / metabolism
  • Phosphatidylinositol 4,5-Diphosphate*
  • RNA / metabolism
  • gag Gene Products, Human Immunodeficiency Virus* / chemistry

Substances

  • gag Gene Products, Human Immunodeficiency Virus
  • Lipids
  • Peptides
  • RNA
  • Phosphatidylinositol 4,5-Diphosphate